Stage 3 Type 1 Diabetes Mellitus

DrugDrug NameDrug Description
DB06606TeplizumabA CD3-directed monoclonal antibody indicated to delay the onset of Stage 3 type 1 diabetes in patients with Stage 2 type 1 diabetes.
DrugDrug NamePhaseStatusCount